Trends in Ciprofloxacin Nonsusceptibility and Levofloxacin Resistance among Streptococcus pneumoniae Isolates in North America
James A. Karlowsky, Leigh Nealy, Daniel F. Sahm, Clyde Thornsberry, Mark E. Jones
Abstract
James A. Karlowsky, Leigh Nealy, Daniel F. Sahm, Clyde Thornsberry, Mark E. Jones
Abstract
Jones and Pfaller recently reported on macrolide and fluoroquinolone resistances among Streptococcus pneumoniae isolates from 36 North American laboratories participating in the SENTRY Antimicrobial Surveillance Program from 1997 to 1999 ([3][1]). Their report is one of several recent publications
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Jones and Pfaller recently reported on macrolide and fluoroquinolone resistances among Streptococcus pneumoniae isolates from 36 North American laboratories participating in the SENTRY Antimicrobial Surveillance Program from 1997 to 1999 ([3][1]). Their report is one of several recent publications
Key concepts: Streptococcus pneumoniae, Levofloxacin, Microbiology, Ciprofloxacin, Streptococcaceae, Antibiotic resistance, Pneumococcal infections, Antibacterial agent